‘Shielders’ in England told they can return to school and work from December 2
Most people who have been ‘shielding’ during lockdown can stop from next week, official guidance says.
England’s extremely clinically vulnerable adults and children are being encouraged back to work and school from next week.
The national lockdown ends on December 2, and Boris Johnson today outlined the next steps.
The Prime Minister told the nation a revised three-tier system will replace the lockdown.
Exactly which areas will be under each tier is set to be announced on Thursday.
The new measures also bring a reset on guidance for the most vulnerable groups, after another four weeks in lockdown.
Throughout the Autumn lockdown, the clinically vulnerable ‘shielding’ group had been asked to stay home as much as possible once again.
The official guidance says the instruction to continue shielding will lift along with the national lockdown on December 2.
It goes on to say the Government will reintroduce specific advice for clinically extremely vulnerable people on how they can protect themselves at each tier.
The Government will constantly monitor the latest evidence and the evolving situation in local areas to keep that advice up to date, the guidance adds.
The guidance for parents says a ‘better understanding of the factors contributing to clinical risk’ means most kids can be removed from the shielding patient list, once it has been discussed with their clinicians.
However anyone with Chronic Kidney Disease Stage 5 and adults with Down’s Syndrome are being added to the shielding list.
As currently shielding people are urged to return to a somewhat more ordinary lifestyle, support will be made available for those who need it in Tier 3 areas via local authorities or volunteer groups, the guidance says.
Supermarket priority delivery slots will also continue for those who have already registered, the official guidance says.
The Government has also made free flu shots available to the household contacts of people on shielding lists.
It comes as more vaccine developments buoys the world.
The Oxford-AstraZeneca team announced its jab had proved 70% effective – and up to 90% in some cases.
The UK scientists’ announcement came hot on the heels of the new from the Pfizer and Moderna’s vaccine teams that research had found their jabs effective.
The UK Government has assured shielding and elderly populations they will be first in the queue for any Covid-19 vaccine which it is hoped will be rolled out within weeks.
Powered by Translate